These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6749759)

  • 21. Wound infection: a controlled clinical and experimental demonstration of synergy between aerobic (Escherichia coli) and anaerobic (Bacteroides fragilis) bacteria.
    Kelly MJ
    Ann R Coll Surg Engl; 1980 Jan; 62(1):52-9. PubMed ID: 6987938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of glucan and cefoxitin in prevention of murine abscess.
    Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
    Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
    Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
    Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic levels in the small intestine.
    Thadepalli H; Mandal AK; Prabhala RH; Brown J
    Surg Gynecol Obstet; 1986 Dec; 163(6):561-7. PubMed ID: 3538455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaerobic coverage for wound prophylaxis. Comparison of cefazolin and cefoxitin.
    Sarap MD; Scher KS; Jones CW
    Am J Surg; 1986 Feb; 151(2):213-5. PubMed ID: 3511760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predominance of Bacteroides of the fragilis group in the fecal flora under the influence of gentamycin and kanamycin].
    García Sánchez JE; Martín Luengo F; Prieto Prieto J; Rodrigo Sánchez N
    Rev Clin Esp; 1978 Jul; 150(1-2):77-80. PubMed ID: 360322
    [No Abstract]   [Full Text] [Related]  

  • 30. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound infection rates following preoperative versus intraoperative commencement of antibiotic prophylaxis.
    Moesgaard F; Lykkegaard Nielsen MC; Justesen T; Scheibel JH
    Eur J Clin Microbiol; 1984 Jun; 3(3):199-202. PubMed ID: 6381047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of war wound infection].
    Kucisec-Tepes N; Bejuk D; Kosuta D
    Acta Med Croatica; 2006 Sep; 60(4):353-63. PubMed ID: 17048790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial counts in experimental, contaminated crush wounds irrigated with various concentrations of cefazolin and penicillin.
    Lammers R; Henry C; Howell J
    Am J Emerg Med; 2001 Jan; 19(1):1-5. PubMed ID: 11146007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis.
    Moesgaard F; Lykkegaard Nielsen MC; Justesen T
    Eur J Clin Microbiol; 1983 Oct; 2(5):459-62. PubMed ID: 6357789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiology in intraabdominal infections: what is the message for clinical studies? (Opinion paper).
    Condon RE
    Infection; 1999; 27(1):63-66. PubMed ID: 10206793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dynamics of intraperitoneal growth and elimination of Escherichia coli and Bacteroides fragilis in porcine faecal peritonitis treated with fosfomycin.
    Berglund J; Andåker L; Skau T; Nyström PO
    J Antimicrob Chemother; 1991 Apr; 27(4):527-33. PubMed ID: 1856131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: hemodynamic changes.
    Soltes S; Shek PN; Mustard RA; Soric I; Bohnen JM; Mittelman MW
    Shock; 1996; 6 Suppl 1():S43-9. PubMed ID: 8828097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conclusion to be derived from in vitro data with respect to in vivo activity.
    Gotoh S
    Clin Ther; 1981; 4 Suppl A():8-17. PubMed ID: 7326694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapeutic effect of cefoxitin on experimental pyelonephritis in rats. Comparative study with cefazilin.
    Une T; Satoh K; Tanaka N; Ogawa H
    Arzneimittelforschung; 1978; 28(9):1599-602. PubMed ID: 582563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.